Lovastatin
Lovastatin is a statin cholesterol medicine used with diet to lower LDL (“bad”) cholesterol and reduce the risk of heart attack and other coronary heart disease problems.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 63 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
Lovastatin is an older, milder statin, on the U.S. market since about 1996 and available generically, that blocks an enzyme the liver uses to make cholesterol; used with diet, it lowers LDL (“bad”) cholesterol and cuts the risk of heart attack in people with high cholesterol or coronary heart disease. Most people tolerate it well, and the complaints that do come up tend to be stomach ones like gas or constipation, along with headache or mild muscle aches. Watch for unexplained muscle pain, tenderness or weakness, especially with dark urine, because it can rarely mean serious muscle breakdown that harms the kidneys; report it promptly.
Clinical pearls
- Take the regular tablet with your evening meal, since lovastatin is meant to go down with food.
- Skip grapefruit juice altogether, because it raises lovastatin levels and with them the risk of muscle damage.
- Tell any prescriber you take lovastatin before starting clarithromycin, erythromycin or antifungals like itraconazole, which must never be combined with it.
- Lovastatin is not used in pregnancy or breastfeeding, so stop it right away and tell your doctor if you become pregnant.
Patient information guide A plain-language walkthrough of Lovastatin, written from its FDA label.
What Lovastatin is used for
▾
Lovastatin is a statin used along with diet for these purposes (per the Lovastatin tablet label):
- Reducing the risk of heart attack, unstable angina and coronary revascularization procedures in people without symptomatic heart disease
- Slowing the progression of coronary atherosclerosis in people with coronary heart disease
- Lowering total and LDL cholesterol in primary hypercholesterolemia
- Lowering total cholesterol, LDL cholesterol and apolipoprotein B in adolescents 10 to 17 with heterozygous familial hypercholesterolemia who meet certain criteria
How Lovastatin works
▾
Lovastatin blocks HMG-CoA reductase, an enzyme your liver uses early in making cholesterol. With less cholesterol made, the liver builds more LDL receptors that pull LDL (“bad” cholesterol) out of the blood. Lovastatin may also lower VLDL, and apolipoprotein B falls as well.
Lovastatin dosage
▾
Lovastatin tablets are taken by mouth with meals, usually once a day with the evening meal. Some people take it in two divided doses. Your prescriber chooses the dose based on your cholesterol goal and adjusts it no more often than every 4 weeks.
- Stay on a cholesterol-lowering diet.
- Some medicines require a lower maximum dose.
- Severe kidney problems call for careful dose increases.
Follow your prescriber and the label for dosing and any missed doses.
Dosing details from the FDA-approved label
From the Lovastatin prescribing information (“Dosage and Administration”). Doses are set by your prescriber for your product, condition, kidney function and age — never change a dose on your own.
- Adult patients
- Usual recommended starting dose is 20 mg once a day given with the evening meal
- Recommended dosing range 10 to 80 mg/day in single or two divided doses
- Patients requiring LDL-C reductions of 20% or more should start on 20 mg/day
- A starting dose of 10 mg may be considered for patients requiring smaller reductions
- Adjustments at intervals of 4 weeks or mor
- Maximum: 80 mg/day
- Give with meals; patient on standard cholesterol-lowering diet
- Patients taking danazol, diltiazem, dronedarone or verapamil
- Begin with 10 mg of lovastatin
- Maximum: 20 mg/day
- Concomitant use with danazol, diltiazem, dronedarone or verapamil
- Patients taking amiodarone
- Dose should not exceed 40 mg/day
- Maximum: 40 mg/day
- Concomitant use with amiodarone
- Adolescent patients (10 to 17 years of age) with heterozygous familial hypercholesterolemia
- Recommended dosing range 10 to 40 mg/day
- Patients requiring LDL-C reductions of 20% or more should start on 20 mg/day
- A starting dose of 10 mg may be considered for smaller reductions
- Adjustments at intervals of 4 weeks or more
- Maximum: 40 mg/day
- Patients with severe renal insufficiency (creatinine clearance < 30 mL/min)
- Dosage increases above 20 mg/day should be carefully considered and, if deemed necessary, implemented cautiously
- Severe renal insufficiency, creatinine clearance < 30 mL/min
Read the label’s full dosing text
DOSAGE AND ADMINISTRATION The patient should be placed on a standard cholesterol-lowering diet before receiving lovastatin tablets and should continue on this diet during treatment with lovastatin tablets (see NCEP Treatment Guidelines for details on dietary therapy). Lovastatin tablets should be given with meals. Adult Patients The usual recommended starting dose is 20 mg once a day given with the evening meal. The recommended dosing range of lovastatin is 10 to 80 mg/day in single or two divided doses; the maximum recommended dose is 80 mg/day. Doses should be individualized according to the recommended goal of therapy (see NCEP Treatment Guidelines and CLINICAL PHARMACOLOGY ). Patients requiring reductions in LDL-C of 20% or more to achieve their goal (see INDICATIONS AND USAGE ) should be started on 20 mg/day of lovastatin tablets. A starting dose of 10 mg of lovastatin may be considered for patients requiring smaller reductions. Adjustments should be made at intervals of 4 weeks or more. Cholesterol levels should be monitored periodically and consideration should be given to reducing the dosage of lovastatin tablets if cholesterol levels fall significantly below the targeted range. Dosage in Patients Taking Danazol, Diltiazem, Dronedarone or Verapamil In patients taking danazol, diltiazem, dronedarone or verapamil concomitantly with lovastatin, therapy should begin with 10 mg of lovastatin and should not exceed 20 mg/day (see CLINICAL PHARMACOLOGY , Pharmacokinetics , WARNINGS , Myopathy/Rhabdomyolysis , PRECAUTIONS , Drug Interactions , Other Drug Interactions ). Dosage in Patients Taking Amiodarone In patients taking amiodarone concomitantly with lovastatin tablets, the dose should not exceed 40 mg/day (see WARNINGS , Myopathy/Rhabdomyolysis and PRECAUTIONS , Drug Interactions , Other Drug Interactions ). Adolescent Patients (10 to 17 Years of Age) With Heterozygous Familial Hypercholesterolemia The recommended dosing range of lovastatin is 10 to 40 mg/day; the maximum recommended dose is 40 mg/day. Doses should be individualized according to the recommended goal of therapy (see NCEP Pediatric Panel Guidelines 4 , CLINICAL PHARMACOLOGY , and INDICATIONS AND USAGE ). Patients requiring reductions in LDL-C of 20% or more to achieve their goal should be started on 20 mg/day of lovastatin tablets.
Excerpted — the section continues on the label. Read the full Dosage and Administration section on DailyMed →
Lovastatin side effects
▾
Most people tolerate lovastatin well. Common effects include:
Common side effects
- Gas (flatulence)
- Constipation
- Abdominal pain
- Diarrhea
- Nausea
- Headache
- Muscle aches (myalgia) or cramps
- Dizziness, rash or blurred vision
When to get medical help
- Call your doctor promptly for unexplained muscle pain, tenderness or weakness, especially with fever or feeling unwell.
- Dark urine with muscle symptoms can signal rhabdomyolysis (severe muscle breakdown that can harm the kidneys); get medical help right away.
- Seek care for signs of liver problems such as jaundice (yellowing of skin or eyes).
- Get urgent help for allergic reactions such as swelling of the face or throat, trouble breathing, or a severe skin rash.
- Muscle weakness that continues after stopping a statin should be reported.
- Tell your doctor about memory loss or confusion; these reports were generally reversible after stopping.
Lovastatin warnings and precautions
▾
- Muscle damage: rarely myopathy or rhabdomyolysis, more likely at higher doses or with interacting drugs. Report unexplained muscle symptoms promptly.
- Liver effects: enzyme rises can occur, and rare serious liver injury has been reported. Liver tests are advised before starting and as needed.
- Blood sugar: increases in HbA1c and fasting glucose have been reported with statins.
- Temporary hold: therapy should be withheld during serious acute conditions such as sepsis, major surgery, trauma or very low blood pressure.
Lovastatin interactions
▾
Several drugs and grapefruit juice can raise lovastatin levels or add to muscle risk.
- Strong CYP3A4 inhibitors (such as ketoconazole, itraconazole, clarithromycin, erythromycin, HIV protease inhibitors, nefazodone): contraindicated because they raise lovastatin levels.
- Grapefruit juice: avoid; it raises lovastatin levels.
- Gemfibrozil and cyclosporine: avoid due to muscle risk.
- Danazol, diltiazem, dronedarone, verapamil, amiodarone: lower dose limits apply.
- Other fibrates, niacin at 1 g/day or more, colchicine, ranolazine: higher muscle risk, so use caution.
- Warfarin-type blood thinners: clotting time should be checked.
Interactions listed in the FDA-approved label
From the Lovastatin prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
- Strong CYP3A4 inhibitors (itraconazole, ketoconazole, posaconazole, voriconazole, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone, erythromycin, cobicistat-containing products) and grapefruit juice: Increase the risk of myopathy by reducing the elimination of lovastatin. See CONTRAINDICATIONS and WARNINGS, Myopathy/Rhabdomyolysis.
- Gemfibrozil, other fibrates, niacin (nicotinic acid) (≥ 1 g/day): The risk of myopathy is increased by these lipid-lowering drugs, which can cause myopathy when given alone. See WARNINGS, Myopathy/Rhabdomyolysis.
- Cyclosporine: The risk of myopathy/rhabdomyolysis is increased. See WARNINGS, Myopathy/Rhabdomyolysis.
- Danazol, diltiazem, dronedarone or verapamil: The risk of myopathy/rhabdomyolysis is increased, particularly with higher doses of lovastatin. Begin with 10 mg lovastatin and do not exceed 20 mg/day.
- Amiodarone: The risk of myopathy/rhabdomyolysis is increased when used with a closely related HMG-CoA reductase inhibitor. Dose of lovastatin should not exceed 40 mg/day.
- Coumarin anticoagulants: Bleeding and/or increased prothrombin time have been reported in a few patients taking coumarin anticoagulants with lovastatin. Determine prothrombin time before starting lovastatin and frequently enough during early therapy; once stable, monitor at usual intervals; repeat the procedure if the lovastatin dose is changed.
- Colchicine: Cases of myopathy, including rhabdomyolysis, have been reported with lovastatin coadministered with colchicine. See WARNINGS, Myopathy/Rhabdomyolysis.
- Ranolazine: The risk of myopathy, including rhabdomyolysis, may be increased. See WARNINGS, Myopathy/Rhabdomyolysis.
- Propranolol: No clinically significant pharmacokinetic or pharmacodynamic interaction with single doses in normal volunteers.
- Digoxin: No effect on digoxin plasma concentrations in patients with hypercholesterolemia.
Read the label’s full interactions text
Drug Interactions CYP3A4 Interactions Lovastatin is metabolized by CYP3A4 but has no CYP3A4 inhibitory activity; therefore it is not expected to affect the plasma concentrations of other drugs metabolized by CYP3A4. Strong inhibitors of CYP3A4 (e.g., itraconazole, ketoconazole, posaconazole, voriconazole, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone, erythromycin, and cobicistat-containing products), and grapefruit juice increase the risk of myopathy by reducing the elimination of lovastatin (see CONTRAINDICATIONS , WARNINGS , Myopathy/Rhabdomyolysis , and CLINICAL PHARMACOLOGY , Pharmacokinetics ). Interactions With Lipid-Lowering Drugs That Can Cause Myopathy When Given Alone The risk of myopathy is also increased by the following lipid-lowering drugs that are not strong CYP3A4 inhibitors, but which can cause myopathy when given alone. See WARNINGS, Myopathy/Rhabdomyolysis. Gemfibrozil Other fibrates Niacin (nicotinic acid) (≥ 1 g/day) Other Drug Interactions Cyclosporine The risk of myopathy/rhabdomyolysis is increased by concomitant administration of cyclosporine (see WARNINGS , Myopathy/Rhabdomyolysis ). Danazol, Diltiazem, Dronedarone or Verapamil The risk of myopathy/rhabdomyolysis is increased by concomitant administration of danazol, diltiazem, dronedarone or verapamil particularly with higher doses of lovastatin (see WARNINGS , Myopathy/Rhabdomyolysis ; CLINICAL PHARMACOLOGY , Pharmacokinetics ). Amiodarone The risk of myopathy/rhabdomyolysis is increased when amiodarone is used concomitantly with a closely related member of the HMG-CoA reductase inhibitor class (see WARNINGS , Myopathy/Rhabdomyolysis ). Coumarin Anticoagulants In a small clinical trial in which lovastatin was administered to warfarin treated patients, no effect on prothrombin time was detected.
Excerpted — the section continues on the label. Read the full Drug Interactions section on DailyMed →
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before taking Lovastatin
▾
- Do not use with active liver disease or unexplained persistent liver enzyme elevations.
- Do not use if allergic to any ingredient.
- Do not use during pregnancy or breastfeeding.
- Tell your doctor about heavy alcohol use or a history of liver disease.
- Tell your doctor about kidney problems, especially severe ones.
- Older adults had higher drug levels in a study.
- Adolescents 10 to 17 may use it only for heterozygous familial hypercholesterolemia.
Lovastatin overdose
▾
In reported accidental overdoses, patients had no specific symptoms and recovered. Healthy volunteers took up to 200 mg as a single dose without significant problems. No specific treatment is recommended, so contact a doctor or poison control if you take too much.
What Lovastatin does in the body
▾
Lovastatin lowers LDL cholesterol and apolipoprotein B. It acts by inhibiting HMG-CoA reductase and may reduce VLDL cholesterol while boosting LDL receptor activity, which increases LDL clearance.
How your body processes Lovastatin
▾
Lovastatin is converted in the body to its active form. It is heavily processed by the liver on first pass, so little reaches the general circulation. Levels peak about 2 to 4 hours after a dose and are higher when taken with food. It is broken down by the CYP3A4 enzyme and cleared mostly in feces (about 83%), with some in urine (about 10%).
How to store Lovastatin
▾
Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) . stored in a well-closed, light-resistant container.
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
Supplements & herbs that interact with Lovastatin
184 supplements and herbal products have documented interactions with Lovastatin in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 8
- Moderate · 140
- Minor · 36
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Nutrient depletion considerations
Lovastatin has been associated with lower levels of 1 nutrient in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.
Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.
Lovastatin: pharmacist answers to common questions
Quick, plain-English answers to the questions patients ask most about Lovastatin — the kind of thing our pharmacy team would talk through with you at the counter.
What is lovastatin for?
▾
How should I take it?
▾
What side effects are common?
▾
When should I call you or my doctor?
▾
Can I drink grapefruit juice or take my other medicines with it?
▾
Is it safe in pregnancy?
▾
Is Lovastatin available over the counter?
▾
When was Lovastatin first available?
▾
Who makes Lovastatin?
▾
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI →
More about Lovastatin on HelloPharmacist
Lovastatin forms and strengths (how it comes)
Lovastatin is available in 1 form. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Tablet
How this form is used
- Lovastatin tablets are used with diet to lower total and LDL cholesterol in primary hypercholesterolemia.
- Lovastatin tablets reduce the risk of heart attack, unstable angina and coronary revascularization in people without symptomatic heart disease.
- Lovastatin tablets slow the progression of coronary atherosclerosis in people with coronary heart disease.
- Lovastatin tablets are used in adolescents 10 to 17 with heterozygous familial hypercholesterolemia who meet the criteria.
- Lovastatin tablets should be taken by mouth with meals.
- Lovastatin tablets are usually taken once daily with the evening meal, but can be given in two divided doses.
- Stay on a cholesterol-lowering diet while taking Lovastatin tablets.
- Follow your prescriber's directions for dose adjustments.
Lovastatin on the U.S. market: products, makers and brands
How Lovastatin appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
17 companies list 72 Lovastatin product records with the FDA, mostly as tablet; the earliest marketing or approval year on record is 1987. Brand names on the directory include Altoprev, Mevacor, Altocor; the rest are generics.
Also listed with the FDA, not a patient dose form: Powder (10) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How widely Lovastatin is used (Medicaid data)
A general measure of how commonly Lovastatin is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Lovastatin is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Lovastatin prescribed? Of the 1,601 medications we measure, Lovastatin ranks #446 by Medicaid prescriptions — more than 72% of them.
Utilization by Lovastatin product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
lovastatin 20 MG Oral Tablet Most dispensed
Summed across the 10 of 115 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197904
lovastatin 40 MG Oral Tablet
Summed across the 10 of 108 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197905
lovastatin 10 MG Oral Tablet
Summed across the 8 of 106 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 197903
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Lovastatin, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 28 of 329 listed Lovastatin NDCs with Medicaid activity.
Compare Lovastatin products
A representative set of FDA-listed product records for Lovastatin — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Tablet | ||||
| 10 mg | Oral | A-S Medication Solutions × 2 listings | ANDA | View NDC → |
| 20 mg | Oral | A-S Medication Solutions × 2 listings | ANDA | View NDC → |
| 40 mg | Oral | A-S Medication Solutions × 2 listings | ANDA | View NDC → |
| 40 mg | Oral | Aphena Pharma Solutions - Tennessee, LLC × 2 listings | ANDA | View NDC → |
| 10 mg | Oral | BluePoint Laboratories | ANDA | View NDC → |
| 20 mg | Oral | BluePoint Laboratories | ANDA | View NDC → |
| 40 mg | Oral | BluePoint Laboratories | ANDA | View NDC → |
| 20 mg | Oral | Boswell Pharmacy Services LLC d/b/a BPS Wholesale | ANDA | View NDC → |
| 40 mg | Oral | Boswell Pharmacy Services LLC d/b/a BPS Wholesale | ANDA | View NDC → |
| 10 mg | Oral | Bryant Ranch Prepack × 5 listings | ANDA | View NDC → |
| 20 mg | Oral | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| 40 mg | Oral | Bryant Ranch Prepack × 2 listings | ANDA | View NDC → |
| 10 mg | Oral | Carlsbad Technology, Inc. | ANDA | View NDC → |
| 20 mg | Oral | Carlsbad Technology, Inc. | ANDA | View NDC → |
| 40 mg | Oral | Carlsbad Technology, Inc. | ANDA | View NDC → |
| 10 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| 20 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| 40 mg | Oral | Golden State Medical Supply, Inc. | ANDA | View NDC → |
| 20 mg | Oral | Legacy Pharmaceutical Packaging, LLC | ANDA | View NDC → |
| 40 mg | Oral | Legacy Pharmaceutical Packaging, LLC | ANDA | View NDC → |
| 10 mg | Oral | Lupin Pharmaceuticals, Inc. | ANDA | View NDC → |
| 20 mg | Oral | Lupin Pharmaceuticals, Inc. | ANDA | View NDC → |
| 40 mg | Oral | Lupin Pharmaceuticals, Inc. | ANDA | View NDC → |
| 20 mg | Oral | NCS HealthCare of KY, LLC dba Vangard Labs | ANDA | View NDC → |
| 40 mg | Oral | NCS HealthCare of KY, LLC dba Vangard Labs | ANDA | View NDC → |
| 10 mg | Oral | Northwind Health Company, LLC × 2 listings | ANDA | View NDC → |
| 20 mg | Oral | Northwind Health Company, LLC | ANDA | View NDC → |
| 40 mg | Oral | Northwind Health Company, LLC | ANDA | View NDC → |
| 10 mg | Oral | NuCare Pharmaceuticals, Inc. | ANDA | View NDC → |
| 10 mg | Oral | NuCare Pharmaceuticals,Inc. × 2 listings | ANDA | View NDC → |
| 20 mg | Oral | NuCare Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 20 mg | Oral | NuCare Pharmaceuticals,Inc. | ANDA | View NDC → |
| 40 mg | Oral | NuCare Pharmaceuticals, Inc. | ANDA | View NDC → |
| 20 mg | Oral | PD-Rx Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 40 mg | Oral | PD-Rx Pharmaceuticals, Inc. × 3 listings | ANDA | View NDC → |
| 20 mg | Oral | Preferred Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 40 mg | Oral | Preferred Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 10 mg | Oral | Preferred Pharmaceuticals Inc. | ANDA | View NDC → |
| 10 mg | Oral | Proficient Rx LP × 3 listings | ANDA | View NDC → |
| 20 mg | Oral | Proficient Rx LP × 4 listings | ANDA | View NDC → |
| 40 mg | Oral | Proficient Rx LP × 3 listings | ANDA | View NDC → |
| 20 mg | Oral | Remedyrepack Inc. | ANDA | View NDC → |
| 40 mg | Oral | Remedyrepack Inc. × 2 listings | ANDA | View NDC → |
| 10 mg | Oral | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
| 20 mg | Oral | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
| 40 mg | Oral | Teva Pharmaceuticals USA, Inc. | ANDA | View NDC → |
Showing 72 of 72 products — FDA National Drug Code Directory. See every product, package size and price: browse all 72 Lovastatin NDCs →
Lovastatin side effects reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Lovastatin — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Lovastatin in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Lovastatin FDA approval history
How Lovastatin went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Lovastatin recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Lovastatin recalls since July 2021.
✅No Lovastatin recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Sep 24, 2026.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 6472 2 dose forms · 6 strengths
-
Dose form (SCDF) Extended Release Oral Tablet RxCUI 378724No current FDA listingClinical drug / strength (SCD) 24 HR lovastatin 20 MGRxCUI 43384924 HR lovastatin 40 MGRxCUI 35973124 HR lovastatin 60 MGRxCUI 359732 -
Dose form (SCDF) Oral Tablet RxCUI 372652In current FDA listings
Look up RxCUI 6472 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Lovastatin supply and shortage status
Whether Lovastatin is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
💵 What Lovastatin costs pharmacies (NADAC benchmark)
The national average invoice price pharmacies pay for the drug itself, from CMS's NADAC survey (data as of Sep 30, 2026). This is a supply-cost benchmark — not a retail price and not what you'd pay at the counter.
| Form | Strength | Pharmacy acquisition benchmark | |
|---|---|---|---|
| Tablet · Oral | 20 mg | $0.044 per tablet | NDC details & price history |
| Tablet · Oral | 40 mg | $0.055 per tablet | NDC details & price history |
| Tablet · Oral | 10 mg | $0.037 per tablet | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC), a survey of retail pharmacy invoice prices. Benchmarks shown are the range across package sizes of a representative product for each form and strength — other manufacturers' products may differ.
Lovastatin brand names
Lovastatin is sold under 3 brand names in the FDA directory — Altoprev, Mevacor, Altocor. A brand and its generic contain the same active ingredient; the brand name belongs to one company's product.
Who makes Lovastatin: manufacturers and labelers
17 companies list Lovastatin products with the FDA. By number of product records, the largest are Proficient Rx LP, Bryant Ranch Prepack, NuCare Pharmaceuticals, Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Lovastatin drug class (RxNorm)
Lovastatin belongs to the HMG-CoA Reductase Inhibitor class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
Sources for this Lovastatin page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Legacy Pharmaceutical Packaging, LLC is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →